BrightSpring officer exercises options, sells shares in offering

Rhea-AI Filing Summary

BrightSpring Health Services (BTSG) reported an insider transaction by its Chief of Staff and SVP, Human Resources. On October 22, 2025, the officer exercised 20,000 stock options at $6.37 per share and sold 20,000 common shares at $28.782 pursuant to a registered public offering that closed the same day.

Following these transactions, the officer directly beneficially owned 131,150 common shares. Derivative holdings listed included 71,578 stock options remaining beneficially owned. The filing notes the options are fully vested.

Insider Trade Summary

Net Seller: 20,000 shares ($575,640)

Net Sell 3 txns

Insider Nalley Lisa A

Role See Remarks

Sold 20,000 shs ($576K)

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to Buy)	20,000	$0.00	--
Exercise	Common Stock	20,000	$6.37	$127K
Sale	Common Stock	20,000	$28.782	$576K

Holdings After Transaction: Stock Options (Right to Buy) — 71,578 shares (Direct); Common Stock — 151,150 shares (Direct)

Footnotes (1)

1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on October 22, 2025, at a price of $28.7820. These options are fully vested.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nalley Lisa A

(Last) (First) (Middle)

C/O BRIGHTSPRING HEALTH SERVICES, INC.

805 N. WHITTINGTON PARKWAY

(Street)

LOUISVILLE KY 40222

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightSpring Health Services, Inc. [ BTSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
10/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/22/2025		M		20,000	A	$6.37	151,150	D
Common Stock	10/22/2025		S(1)		20,000	D	$28.782(1)	131,150	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$6.37	10/22/2025		M			20,000	(2)	09/24/2029	Common Stock	20,000	$0	71,578	D

Explanation of Responses:

1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on October 22, 2025, at a price of $28.7820.

2. These options are fully vested.

Remarks:

Title: Chief of Staff and Senior Vice President, Human Resources

	/s/ Jennifer Phipps, as Attorney-in-Fact	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BTSG's officer report on Form 4?

An exercise of 20,000 stock options at $6.37 and a sale of 20,000 shares at $28.782 on October 22, 2025.

Was the BTSG share sale part of an offering?

Yes. The 20,000 shares were sold pursuant to a registered public offering that closed on October 22, 2025.

How many BTSG shares does the officer own after the transactions?

Directly beneficially owned shares totaled 131,150 following the reported transactions.

What BTSG derivatives does the officer still hold?

The filing lists 71,578 stock options beneficially owned; the options are fully vested.

What prices were involved in the BTSG transactions?

Option exercise price was $6.37 per share; sale price was $28.782 per share.

What is the officer’s role at BrightSpring (BTSG)?

The reporting person is the Chief of Staff and Senior Vice President, Human Resources.